We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

44 hedge funds and large institutions have $4.47M invested in Pear Therapeutics, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 51 → 44 (-7)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

44% less capital invested

Capital invested by funds: $7.97M → $4.47M (-$3.5M)

82% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 11

Holders
44
Holders Change
-7
Holders Change %
-13.73%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
2
Reduced
11
Closed
21
Calls
$2.51M
Puts
–
Net Calls
+$2.51M
Net Calls Change
-$271K

Top Buyers

Rank Fund Capital Flow
1
OCAM
Owl Creek Asset Management
New York
+$420K
2
BlackRock
BlackRock
New York
+$248K
3
AR
Advisory Research
Illinois
+$217K
4
MA
MYDA Advisors
New York
+$60.9K
5
WAM
Wolverine Asset Management
Illinois
+$42.4K

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$1.82M
2
BCM
BlueCrest Capital Management
Jersey
-$317K
3
MF
Magnetar Financial
Illinois
-$262K
4
GCL
Glazer Capital LLC
New York
-$233K
5
Citadel Advisors
Citadel Advisors
Florida
-$200K
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
51
Periscope Capital
Ontario, Canada
– -$45K -48,067 Closed
Blackstone Inc
52
Blackstone Inc
New York
– -$40K -41,666 Closed
AA
53
AQR Arbitrage
Connecticut
– -$38K -40,333 Closed
MI
54
MMCAP International
Cayman Islands
– -$32K -33,333 Closed
MIM
55
Monashee Investment Management
Massachusetts
– -$32K -33,332 Closed
Nomura Holdings
56
Nomura Holdings
Japan
– -$24K -25,132 Closed
Parallax Volatility Advisers
57
Parallax Volatility Advisers
California
– -$18K -18,524 Closed
Bank of America
58
Bank of America
North Carolina
– -$16K -16,666 Closed
CH
59
CVI Holdings
Delaware
– -$16K -16,666 Closed
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
– -$12K -12,305 Closed
ACM
61
Atalaya Capital Management
New York
– -$8K -8,333 Closed
CAPTRUST Financial Advisors
62
CAPTRUST Financial Advisors
North Carolina
– -$2K -1,889 Closed
PFGIA
63
Patriot Financial Group Insurance Agency
Massachusetts
– +$169 +166 New
Morgan Stanley
64
Morgan Stanley
New York
– +$751 +740 New
1 2
3

PEARW Hedge Fund Activity: Q4 2021 in Review

44 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q4 2021, worth a combined $4.47M — down 44% from $7.97M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of PEARW and 14 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 2 added.

The largest buyer was Owl Creek Asset Management, opening a new position worth an estimated $420K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.82M sold.

  • 44 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q4 2021, down from 51 in Q3 2021.
  • Funds reported $4.47M of Pear Therapeutics, Inc. Warrant stock for Q4 2021, down 44% quarter-over-quarter.
  • 14 funds opened new Pear Therapeutics, Inc. Warrant positions in Q4 2021 and 21 closed out, a net change of -7 holders.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q4 2021 was Owl Creek Asset Management, an estimated $420K added.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q4 2021 was Radcliffe Capital Management, an estimated $1.82M sold.

Based on aggregated 13F filings for Q4 2021.